Innogene Kalbiotech
Singapore, Singapore· Est.
Asian‑focused biotech delivering oncology biologics, biosimilars, and precision diagnostics across ASEAN.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Asian‑focused biotech delivering oncology biologics, biosimilars, and precision diagnostics across ASEAN.
Oncology
Technology Platform
Recombinant protein expression and cell line development for biologics/biosimilars combined with IVDMIA‑based precision diagnostic assays and full‑service BA/BE and CMO capabilities.
Opportunities
Expanding biosimilar and precision oncology diagnostic offerings across the fast‑growing ASEAN market and leveraging CMO services for external partners.
Risk Factors
Regulatory heterogeneity across Asian markets, intense competition from global biosimilar manufacturers, and reliance on parent company’s financing.
Competitive Landscape
Competes with regional biosimilar producers and multinational players such as Sandoz, Mylan, and Amgen, differentiating through integrated diagnostics and strong local regulatory expertise.